First, the specific mechanism of CDCA3 on CD8+T cells and its influence on immunotherapy of renal cell carcinoma need to be further explored; second, we have proved that CDCA3 can block the cell cycle, but there is no further study on the biological mechanism. The gene discussed is CDCA3; the disease is renal cell carcinoma.